Cardinal Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardinal Health (CAH).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

15Buy

2Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$224Upside to Avg. PT-1.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 19, 2026	RBC Capital	Ryan Halsted	Initiate	Outperform	$276
Aug 13, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$275→$280
Aug 13, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$215→$260
Aug 13, 2026	Barclays	Glen Santangelo	PT Raise	Overweight	$258→$275
Aug 12, 2026	Citigroup	Daniel Grosslight	PT Raise	Buy	$265→$280
Aug 12, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$265→$270
Aug 12, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$255→$265
Aug 12, 2026	Mizuho	Steven Valiquette	PT Raise	Outperform	$240→$250
Aug 12, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$274→$280
Aug 12, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$245→$277
Aug 12, 2026	Baird	Eric Coldwell	PT Raise	Outperform	$251→$274
Jul 24, 2026	Citigroup	Daniel Grosslight	PT Raise	Buy	$245→$265
Jul 23, 2026	Mizuho	Steven Valiquette	PT Raise	Outperform	$235→$240
Jul 20, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$260→$274
Jul 9, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$255→$275
Jul 2, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$240→$260
May 4, 2026	JP Morgan	Lisa Gill	PT Cut	Neutral	$243→$215
May 1, 2026	Citigroup	Daniel Grosslight	PT Cut	Buy	$249→$245
May 1, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$251→$255
May 1, 2026	Wells Fargo	Stephen Baxter	PT Cut	Overweight	$256→$245

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.

Benzinga Newsdesk

Cardinal Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Cardinal Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

People Also Watch

People Also Watch

Cardinal Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Cardinal Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

PROTD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

PROJP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

PROBarclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

PROEvercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

PROMorgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

People Also Watch

People Also Watch

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265